← Evidence map

ArticleMolecular cancer therapeutics2017

Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model.

Kun-Yu Teng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

89 papers cite itlatest 60 shown

2017
…
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 27980102